26.02.2020 • News • Elaine Burridge • Avantium

Avantium Divests Bioaromatics Portfolio

Avantium Divests Bioaromatics Portfolio (c) Avantium
Avantium Divests Bioaromatics Portfolio (c) Avantium

Dutch renewables specialist Avantium has sold its bioaromatics patent portfolio to The Netherlands Organization for Applied Scientific Research, TNO, for an undisclosed sum.

The sale includes patents and know-how for technologies that produce bio-derived products for polymers and coatings. Avantium said these technologies lie outside its strategic focus and will now be developed further by TNO.

“This bioaromatics patent portfolio fits well into TNO’s development strategy. Avantium will continue to support TNO in this area and can provide proprietary single flow testing equipment to accelerate TNO’s R&D efforts,” said Zanna McFerson, managing director of Avantium Renewable Chemistries.

Last month, Avantium Renewable Polymers signed a letter of intent to build a 5,000 t/y plant for bio-based furandicarboxylic acid (FDCA), a key building block for polyethylene furanoate (PEF). The facility, located at Chemie Park Delfzijl in the Netherlands, is expected to start production in 2023.

Innovation Pitch

The Start-up Platform for Chemistry & Life Sciences
Discover Tomorrow’s Innovators

The Start-up Platform for Chemistry & Life Sciences

CHEManager Innovation Pitch supports innovation in the chemistry and life sciences start-up scene. The platform allows founders, young entrepreneurs, and start-ups to present their companies to the industry.

Whitepaper

Excellence in Pharmaceutical Distribution and The Critical Role of Good Distribution Practice (GDP)
Setting the Standard

Excellence in Pharmaceutical Distribution and The Critical Role of Good Distribution Practice (GDP)

Are you ready to elevate your pharmaceutical operations? Download our exclusive whitepaper and discover how compliance with Good Distribution Practice (GDP) is essential for the safety and integrity of pharmaceuticals.

Top-Feature